Correlation of the rate of metastasis-free survival with the presence of pathogenic germline genetic mutations in patients with prostate cancer at a community practice.

被引：0
作者：
Ramanathan, Siddharth
Ramanathan, Sadhna
Martinez, Alvaro
Korman, Andrew
Ghilezan, Michael
Levin, Michael
Gerndt, Zachary Alan
Shen, Nathan
Wojno, Kirk
Korman, Howard
Balaraman, Savitha
机构：
[1] Oakland Univ, William Beaumont Sch Med, Bloomfield Hills, MI USA
[2] 21st Century Oncol, Farmington Hills, MI USA
[3] Univ Maryland, College Pk, MD USA
[4] Michigan Healthcare Profess, Farmington Hills, MI USA
[5] Comprehens Urol, Farmington Hills, MI USA
[6] Comprehens Urol, Royal Oak, MI USA
[7] Cent Michigan Univ, Sch Med, Mt Pleasant, MI USA
[8] Michigan Healthcare Profess, Royal Oak, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Genetic testing and management of prostate cancer patients with pathogenic germline variants
    Reiter, Katharina
    Hassler, Melanie R.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (01) : 51 - 56
  • [22] Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survival
    Svenson, Ulrika
    Roos, Goran
    Wikstrom, Pernilla
    TUMOR BIOLOGY, 2017, 39 (02)
  • [23] Positive Prostate Biopsy Following Radiation Therapy Can Predict Metastasis-Free Survival In Localized Prostate Cancer
    Zapatero, A.
    Fernandez Banda, L.
    Buscher, D.
    Torres, L.
    Cruz Conde, A.
    Martin de Vidales, C. C.
    Adrados, M.
    Olivier, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E150 - E150
  • [24] Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
    Xie, W.
    Ravi, P.
    Buyse, M.
    Halabi, S.
    Kantoff, P.
    Sartor, O.
    Soule, H.
    Clarke, N.
    Dignam, J.
    James, N.
    Fizazi, K.
    Gillessen, S.
    Mottet, N.
    Murphy, L.
    Parulekar, W.
    Sandler, H.
    Tombal, B.
    Williams, S.
    Sweeney, C. J.
    ANNALS OF ONCOLOGY, 2024, 35 (03) : 285 - 292
  • [25] Association of metastasis-free survival (MFS) and overall survival (OS) in nonmetastatic castration-resistant prostate cancer (nmCRPC).
    Smith, Matthew Raymond
    Mehra, Maneesha
    Nair, Sandhya
    Lawson, Joe
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] KIF11: A potential prognostic biomarker for predicting bone metastasis-free survival of prostate cancer
    Wang, Haoyuan
    Li, Sijie
    Liu, Bin
    Wei, Shufei
    Wang, Tianyi
    Li, Tao
    Lin, Jiahu
    Ni, Xiaochen
    ONCOLOGY LETTERS, 2022, 24 (03)
  • [27] Payer Acceptability of Metastasis-Free Survival as the Primary Endpoint in Nonmetastatic Castration-Resistant Prostate Cancer
    Krieger, Laurence
    Degener, Fabian
    Naidoo, Shevani
    Holmstrom, Stefan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 193 - 193
  • [28] A Prognostic Gene Signature for Metastasis-Free Survival of Triple Negative Breast Cancer Patients
    Lee, UnJin
    Frankenberger, Casey
    Yun, Jieun
    Bevilacqua, Elena
    Caldas, Carlos
    Chin, Suet-Feung
    Rueda, Oscar M.
    Reinitz, John
    Rosner, Marsha Rich
    PLOS ONE, 2013, 8 (12):
  • [29] Preoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer
    Dahmani, Cylia
    Caron, Patrick
    Simonyan, David
    Lacombe, Louis
    Aprikian, Armen
    Saad, Fred
    Carmel, Michel
    Chevalier, Simone
    Levesque, Eric
    Guillemette, Chantal
    JOURNAL OF UROLOGY, 2023, 209 (02) : 337 - 346
  • [30] Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival
    Bertucci, F.
    Ueno, N. T.
    Finetti, P.
    Vermeulen, P.
    Lucci, A.
    Robertson, F. M.
    Marsan, M.
    Iwamoto, T.
    Krishnamurthy, S.
    Masuda, H.
    Van Dam, P.
    Woodward, W. A.
    Cristofanilli, M.
    Reuben, J. M.
    Dirix, L.
    Viens, P.
    Symmans, W. F.
    Birnbaum, D.
    Van Laere, S. J.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 358 - 365
12345